Huanxi Media Group Limited Overview
Huanxi Media is an asset-light Chinese film and series investment house. Its original edge was ownership alignment: two of China's most bankable creators, director Ning Hao and actor-director Xu Zheng, are founding shareholders. Around them sits a roster of "shareholder directors" and contracted auteurs, including Zhang Yimou, Peter Chan, Wong Kar Wai, Zhang Yibai, Gu Changwei, Jia Zhangke, Wang Xiaoshuai and Chen Daming, who grant Huanxi priority or exclusive investment and new-media rights. The model is extremely hit-dependent. Full River Red (2023, RMB4.5bn+ box office) produced the only profitable year of the last five, and every other year produced losses. After two disappointing 2025 releases, a HK$498m FY2025 loss and a going-concern material-uncertainty paragraph, the company has repositioned as an "AI + film" story. It has raised HK$225m from new investor C River and tried to pivot toward AI-enabled production, but its Phancy (6682.HK) equity deal collapsed on 30 Sep 2026. It now has a 50-person team, no bank debt and a pipeline of unreleased films awaiting approval and release windows.
Company's own description (paraphrased from AR2025 and FY2025 results)
The company describes itself as an investment holding and film investment company. Its subsidiaries carry on media and entertainment businesses in two areas: developing and investing in film and TV programme rights, and operating an online video platform. Because PRC law restricts foreign ownership of internet audio-visual and certain media businesses, PRC operations are controlled through VIE contractual arrangements. The stated strategic creed is "Content is King" (內容為王). Since H2 2025 this has been paired with deploying AI in production and operations.
Independent characterisation
Huanxi is in substance a slate financier and lead producer ("主控出品") of a small number of premium theatrical films each year. Distribution is outsourced, with Maoyan Entertainment's group the dominant counterparty. Revenue has three sources:
-
Share of box office income: the producer's net share after cinema, distributor and tax deductions. This is the dominant stream: 85% of FY2025 revenue and 97% of FY2023.
-
Sub-licensing of film and TV rights: post-theatrical streaming, TV and new-media licences.
-
Other media-related revenue: mainly the huanxi.com subscription platform, co-membership arrangements and related income. This stream has shrunk to HK$2.8m in FY2025.
A fourth line, film investment income/(loss), captures fair-value-type returns on minority film-rights investments carried at FVTPL.
A distinctive balance-sheet feature is "film investment funds from investors" (HK$430m at 30 Jun 2026). Third-party co-investors fund Huanxi-held film rights and recoup from theatrical income. These liabilities behave like project-level, performance-linked quasi-debt. They produce gains when films underperform (investors share losses) and losses when films outperform (as in FY2023, a HK$268m loss).
Revenue model mix
| Stream | FY2025 | % of gross revenue + investment income |
|---|---|---|
| Share of box office income (theatrical "product") | 286.9 | 83.9% |
| Sub-licensing of rights (licensing) | 47.5 | 13.9% |
| Other media revenue incl. platform (subscription/service) | 2.8 | 0.8% |
| Film investment income, net (investment) | 4.9 | 1.4% |
| Total | 342.1 | 100% |
Value-chain position, customers and end-markets
Position: Upstream content origination, financing and lead production. Huanxi does not own cinemas, does not distribute films itself, and has no material physical production assets (PP&E only HK$1.1m).
Customers: Distributors (the largest customer, a Maoyan group company, was 83.45% of FY2025 turnover; the top five were 98.70%), streaming platforms (licensees), and retail subscribers of huanxi.com.
Suppliers: Production companies, creative talent and licensors (the top five suppliers were 94.61% of FY2025 purchases; the largest was 37.03%).
End-markets: The PRC theatrical market (substantially all revenue) and the PRC online video (SVOD) market. Hong Kong houses the holding and finance functions.
Strategy
Stated strategy themes (AR2025 CEO statement; Interim 2026 Prospects)
-
"Content is King" (內容為王): premium, genre-diverse films from top directors, with release timing managed against market conditions.
-
"Intelligent film and television" transformation: AI in script development, filming support, post-production and VFX, introduced in phases.
-
huanxi.com: curate global arthouse and festival titles and explore copyright partnerships.
-
Prudent operation: cost control, streamlining of administrative costs and remuneration, and collection of receivables.
-
Adjacencies: interactive entertainment, game development and IP-derivative products (named in use-of-proceeds disclosures).
Initiatives in the last 24 months
| Initiative | Date | Detail | Status (Oct 2026) |
|---|---|---|---|
| C River equity and warrant raise | Nov 2025 – Apr 2026 | 727.6m shares at HK$0.30 (gross HK$218.3m) + 731.3m warrants at HK$0.01 (gross HK$7.3m), exercisable at HK$0.44 for 5 years; net HK$225.1m | Completed 21 Apr 2026; HK$80.0m utilised by 30 Jun 2026 |
| StepFun (上海階躍星辰) strategic cooperation | Nov 2025 | JV-platform framework covering data cooperation and large-model exploration in film creation, interactive entertainment, games, IP derivatives and AI animation | Framework only; no JV formation disclosed |
| Phancy Group (6682.HK) partnership | 19 May 2026 | (i) Subscription of 731.3m shares at HK$0.275 (HK$201.1m gross; would have been 14.30% of enlarged capital); (ii) strategic cooperation and JV framework; (iii) first Large Model API agreement of US$20m over 2 years, prepaid; (iv) target of ≥US$200m of token-based API spend over 3 years | Share subscription terminated 30 Sep 2026. Status of the API and framework agreements after termination is not disclosed in sources reviewed. |
| Cost programme | FY2025 – H1 2026 | Headcount 85 → 50; H1 2026 administrative expenses down 33.5% YoY; management remuneration adjustment | Ongoing |
| Release-timing discipline | H1 2026 | Theatrical release of new films suspended amid weak market conditions | Ongoing |
| Bye-law modernisation | Apr–Jun 2026 | Electronic communications and voting, treasury-share flexibility | Approved at the 9 Jun 2026 AGM |
| ESG | FY2025 | Carbon-neutrality target of 2050; GHG emissions down 16% | Reported |
Use of C River proceeds
| Use | Allocated | Utilised | Unutilised | Target date |
|---|---|---|---|---|
| AI team | 60.0 | 0 | 60.0 | Dec 2026 |
| AI hardware | 20.0 | 0 | 20.0 | Dec 2026 |
| AI software/applications | 20.0 | 0 | 20.0 | Dec 2026 |
| Film/TV rights (≥1 PRC title) | 50.0 | 42.2 | 7.8 | Dec 2026 |
| General working capital | 75.1 | 37.8 | 37.3 | Dec 2026 |
| Total | 225.1 | 80.0 | 145.1 | — |
Guidance and medium-term targets
Huanxi provides no quantitative financial guidance or medium-term targets. Qualitative guidance: Li Na is "expected to contribute revenue and improve the Group's performance"; release dates depend on approvals, market conditions and distribution; and AI benefits will take time. Profit or loss "alerts" under Rule 13.09 (for example, the 21 Aug 2026 reduction-in-loss announcement, which estimated a loss of HK$39–41m) are the only numeric forward indications.
Products & Services
The group sells individual films, web series and platform access rather than continuing product lines. The catalog below is organised by release status. Pricing of individual titles is not disclosed; box office numbers are total PRC gross, not Huanxi's share.
Released theatrical films and series (selected, attributable to Huanxi as investor or producer)
| Title | Director / key talent | Year | Huanxi role | Performance / note | Source |
|---|---|---|---|---|---|
| Dying to Survive (我不是藥神) | Wen Muye; co-produced by Ning Hao & Xu Zheng | 2,018 | Theatrical slate | RMB3.1bn box office | AR2025; THR |
| Ash Is Purest White (江湖兒女) | Jia Zhangke | 2,018 | Theatrical slate | Cannes 2018 competition | THR; AR2025 |
| Crazy Alien (瘋狂的外星人) | Ning Hao; Huang Bo, Shen Teng | 2019 (CNY) | Exclusive investor | RMB2.2bn box office; RMB2.8bn minimum guarantee; RMB700m revenue to group | AR2025 |
| Lost in Russia (囧媽) | Xu Zheng | 2020 (CNY) | Producer/rights | Premiered online via ByteDance platforms | AR2025; uSmart |
| Leap (奪冠) | Peter Chan; Gong Li | 2,020 | Producer, exclusive new-media rights | National Day 2020 release | AR2025; uSmart |
| One Second (一秒鐘) | Zhang Yimou | 2,020 | Producer | Released 2020 | AR2025 |
| Run For Young (風犬少年的天空) — web series | Zhang Yibai | 2,020 | Exclusive investor | Simulcast on huanxi.com and Bilibili | AR2025; uSmart |
| 尋漢計 | Tang Danian; Ren Suxi | H1 2021 | Producer | Theatrical | Interim 2021 |
| Are You Lonesome Tonight? (熱帶往事) | Wen Shipei; produced by Ning Hao | H1 2021 | Co-producer | Theatrical | Interim 2021 |
| Full River Red (滿江紅) | Zhang Yimou; Jackson Yee, Shen Teng | 22 Jan 2023 | Investor & lead producer | RMB4.5bn+ box office; China's #1 film of 2023; drove the FY2023 profit | AR2023; AR2025 |
| Papa (學爸) | Su Liang; Huang Bo | 2,023 | Investor | Hanna Pictures cooperation | AR2025 |
| The Movie Emperor (紅毯先生) | Ning Hao; Andy Lau | Q1 2024 | Investor & producer | The only FY2024 release; FY2024 box office share HK$63.6m | AR2025; FY2025 results |
| She's Got No Name (醬園弄·懸案) | Peter Chan; Zhang Ziyi, Lei Jiayin | 21 Jun 2025 | Investor & lead producer | About RMB375m box office vs. RMB550m reported two-part budget; Part II pending | World Journal; AR2025 |
| The Stage (戲台) | Chen Peisi; Huang Bo | 2,025 | Investor & lead producer | Below expectations per management | AR2025 |
Pipeline (status as of H1 2026 interim report)
| Title | Director / cast | Status | Expected timing | Source |
|---|---|---|---|---|
| Li Na (獨自·上場) | Peter Chan; Hu Ge, Vincent Cassel, Hao Lei | Completed; release licence application in progress | "When appropriate"; earlier guided to 2026 | Interim 2026; AR2025 |
| Unspoken (以父親之名), formerly 無所畏懼 | Chen Daming; Zhang Hanyu | Post-production / approvals | Earlier guided to 2026 | Interim 2026 |
| Intercross (人魚) | Cheng Er; Wang Yibo, Wang Chuanjun | Participating investor; approvals | To be determined | Interim 2026 |
| Deep In The Mountains (如意飯店) | Li Yongyi; Qiao Shan, Wang Yanhui, Yang Zishan | Post-production / approvals | To be determined | Interim 2026 |
| Full River Red II (滿江紅II) | Zhang Yimou | Early conceptual development; discussions continuing | — | Interim 2026 |
| The Mountain (上山) | Produced by Wang Xiaoshuai | Completed | Earlier guided to 2026 | AR2025 appendix |
| Call Me Crazy (刺猬) | Gu Changwei; Ge You, Karry Wang | Completed per FY2023 results | — | FY2023 results |
| Strangers When We Meet (朝雲暮雨) | Zhang Guoli; Zhou Dongyu | Completed per FY2023 results | — | FY2023 results |
| Evacuate From The 21st Century (從21世紀安全撤離) | Li Yang; Zhang Ruoyun | Invested per FY2023 results | — | FY2023 results |
| Paradise Guesthouse (天堂旅館) — 12-episode web series | Wong Kar Wai (producer/co-director) | Development | — | AR2025 appendix |
| She's Got No Name Part II | Peter Chan | Not formally announced | — | World Journal |
Rights and pipeline contracts (the "director roster")
| Counterparty | Key rights to Huanxi (summarised from AR2025 appendix) |
|---|---|
| Ning Hao (shareholder director) | Founding partner; directed Crazy Alien and The Movie Emperor |
| Xu Zheng (shareholder director) | Founding partner; Lost in Russia |
| Peter Chan (shareholder director) | Investment right in at least 2 films, up to 60% of each budget; priority on global exclusive new-media licences |
| Wong Kar Wai (shareholder director) | Exclusive investment in an 18-episode, two-season web series; 10-year global new-media rights |
| Zhang Yibai (shareholder director) | Priority investment of ≥55% in at least 2 productions; exclusive rights to two web-series seasons |
| Gu Changwei (shareholder director) | Exclusive investment in two web-series seasons; priority film investment |
| Zhang Yimou (shareholder director) | Exclusive investment in 3 web series; one convertible into a priority film right at ≥60% of budget |
| Huang Bo / Hanna Pictures | Co-investment and development (from June 2021) |
| Chen Daming | Priority investment in at least 3 productions; two web-series seasons |
| Jia Zhangke | Exclusive or priority investment in at least 3 new films; exclusive new-media rights |
| Wang Xiaoshuai | Priority investment in 2 productions; global new-media exclusivity |
| Manfred Wong | Priority investment in at least 4 productions |
huanxi.com (歡喜首映) online video platform
Description: A subscription-based, advertising-free premium SVOD service for PC, mobile and TV, operated through the VIE licence holder Beijing Hangaohua. It carries Huanxi originals plus curated arthouse and festival imports.
2025–2026 acquisitions: Eiffel, My Brothers and I, Incredible But True, The Braves (2025); Being Towards Death, I Swear, The Butcher's Blade (H1 2026); planned additions The Rental, The Woman Who Ran, Hinterland and The Forger.
Distribution partners (historical): Bilibili (dedicated channel), Maoyan, ByteDance, Huawei Video, Xiaomi, Mango TV, XGIMI, Skyworth, Hisense, and China Mobile (digital cinema, 2021).
Scale (historical, company-sourced): 1.2m paying subscribers (2019, Hollywood Reporter); more than 35m app downloads and more than 10m cumulative paying users by H1 2021 (uSmart). Current subscriber numbers are not publicly disclosed.
Pricing: Not publicly disclosed in sources reviewed.
Financial weight: "Other media revenue" fell from HK$48.1m (FY2021) to HK$2.8m (FY2025). This implies the platform is now commercially marginal.
AI-enabled production initiative (new, 2025–2026)
Scope: AI applications in script development, filming support, post-production VFX and "customised content for directors". Management also intends to explore interactive entertainment, game development and IP derivatives.
Funding: HK$100m of C River proceeds earmarked for AI: HK$60m for an AI team, HK$20m for hardware and HK$20m for software. All of it was unutilised at 30 Jun 2026.
Launch status: No commercial AI product has been launched. Management says the initiative is "early stage" and that its financial contribution will take time.
Financial Narrative
Income statement
Sources: FY2025, FY2023 and FY2022 results announcements. FY2021 operating and pre-tax income from TipRanks; FY2021 net loss confirmed by the FY2022 results (HK$235.557m). FY2025 aggregator EBITDA is derived from etnet's -29.742% EBITDA margin. The two EBITDA definitions diverge sharply; see commentary.
Margins (%)
The FY2021 gross margin comes from etnet; TipRanks reports a different FY2021 gross loss (HK$119.8m), so this figure is a source discrepancy and should not be relied on.
Revenue CAGR FY2021–FY2025: about 21.2% per year (158.4 → 342.1). This is not a meaningful growth indicator, because revenue swings by roughly 100x depending on whether a hit is released (FY2022: HK$13.6m; FY2023: HK$1,333m).
Half-year P&L (HK$ m)
Key expense lines by nature (HK$ m)
Commentary — P&L.
FY2023 was the inflection: Full River Red generated HK$1.29bn of box office share and a 68% gross margin. Even so, net profit was only HK$159m. Three items absorbed the gross profit: HK$319m of P&A spend, a HK$268m loss on investor-fund arrangements (co-investors took a share of the upside), and HK$106m of forward-looking impairments.
FY2024 revenue collapsed: to HK$34m with a single release, The Movie Emperor. A HK$51m film-investment loss deepened the hole.
FY2025 shows the structural problem: revenue rose 10x to HK$342m on two releases, but cost of revenue of HK$580m exceeded it. That cost included HK$396m of amortisation, and the two films missed expectations. On top came a HK$184.5m impairment as expected revenues on the remaining library were cut, and a HK$63.7m credit impairment. The result was the largest loss in the period, HK$498m.
H1 2026: The company deliberately released nothing. Revenue fell 97% and the loss narrowed 61%, helped by a HK$17.7m (33%) reduction in administrative expenses. This is a holding pattern, not a recovery.
Balance sheet
Sources: results announcements for FY2021–FY2025. FY2021 cash from etnet's cash-flow page (Stockopedia shows HK$119m, which may include other short-term items). FY2021 working capital from Stockopedia current assets (1,338) less current liabilities (578). No goodwill is recognised in any filing reviewed. FY2021 NAV per share is derived from equity and 3,656m shares.
30 June 2026 snapshot (HK$ m): total assets 1,620.4; cash 260.9; film rights 906.0; prepayments for rights 347.9; borrowings nil; lease liabilities 9.5; film investment funds from investors 430.3; total equity 907.6; net current assets 184.4; current ratio 1.27.
Commentary — balance sheet.
Equity erosion: Equity fell 58% from HK$1.66bn (FY2021) to HK$0.70bn (FY2025) before the April 2026 equity injection.
Content assets are written down, not monetised: Film rights shrank from HK$1.33bn (FY2023) to HK$0.84bn (FY2025). Completed rights fell from HK$930m to HK$506m in FY2025 alone, through amortisation of the two releases plus HK$127.6m of impairment on completed titles.
No bank leverage, but meaningful quasi-debt: The group carries HK$430m of investor funds. HK$230.3m of this, owed to a single investor, was originally due on 30 Jun 2026 and remains under negotiation.
Receivables quality is poor: HK$93.5m of trade payables are aged over 365 days, and most net trade receivables are also older than 365 days. Combined trade and other receivable loss allowances reached HK$83.5m in FY2025.
Cash flow
Source: etnet cash-flow summary derived from annual reports. Capex is not separately broken out in the sources reviewed, but PP&E balances of HK$1–2m imply capex is immaterial, so the FCF proxy is close to OCF. A 2021 buyback of 33.15m shares was reported by uSmart, but its value was not disclosed. No buybacks occurred in FY2023 or FY2025 per the filings; FY2022 and FY2024 are taken from the absence of any disclosed buyback.
Commentary — cash flow. Cash generation is lumpy and mostly negative. Production cash goes out years before release, and box office cash arrives 3–9 months after release. The large FY2021 operating outflow (HK$470m) was the build-up of the Full River Red, Li Na and She's Got No Name slate, funded mainly by FY2021 financing inflows of HK$441m. The aggregator's weighted-average share count also rose from 3.25bn (FY2020) to 3.60bn (FY2021), which suggests share issuance. Cash fell from HK$310m (FY2023) to HK$88m (FY2025) before the C River proceeds lifted it to HK$261m at H1 2026.
Ratios
The cash conversion cycle is not publicly disclosed and is not meaningful for a film-rights business, which has no inventory and very long-dated receivables and payables. Net debt/EBITDA is mathematically defined for FY2022, FY2024 and FY2025 only because both inputs are negative, so it has no analytical meaning in those years. Only FY2023 (net cash of about 1.3x EBITDA) is interpretable.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansFinancial Detail
Group Entities
| Entity | Role | Ownership / control | Source |
|---|---|---|---|
Huanxi Media Group Limited (Bermuda) | Listed holdco; investment holding and film investment | Listed | AR2025 |
Beijing Huan Sheng Xiao Yu Culture Media Co. (北京歡聲笑語) | PRC WFOE; exclusive services provider to the VIE | Wholly owned | AR2025 |
Beijing Huanxi Shou Ying Culture Co. (北京歡喜首映) — VIE | Film/TV production and investment; GM is ED Hu Hui | 100% registered to Ni Kelu, controlled via contracts | AR2025 |
Beijing Hangaohua Network Technology Co. (北京漢高華) | Holds the internet audio-visual programme service licences; operates the platform | 80% VIE / 20% Gu Haibin | AR2025 |
Qingdao Huanxi Shou Ying | Former VIE subsidiary | Deregistered 21 Aug 2024 | AR2025 |
Joint operations (two films) | Co-production arrangements | 50%–55% participating interests; carrying value HK$110.3m (FY2025) | FY2025 note 14(e) |
Revenue stream (HKD Mn)
| Revenue stream (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Share of box office income | — | 0 | 1,292.5 | 63.6 | 286.9 |
Sub-licensing of film/TV rights | — | 4.3 | 83.8 | 15.6 | 47.5 |
Other media-related revenue (incl. platform) | 48.1 | 12.1 | 35.8 | 5.8 | 2.8 |
Film investment income/(loss), net | — | -2.7 | -79.3 | -50.8 | 4.9 |
Total revenue + film investment income | 158.4 | 13.6 | 1,332.8 | 34.2 | 342.1 |
Revenue stream (%)
| Revenue stream (%) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Share of box office income | 0 | 97.0 | 186.0 | 83.9 |
Sub-licensing | 31.2 | 6.3 | 45.5 | 13.9 |
Other media revenue | 88.8 | 2.7 | 17.0 | 0.8 |
Film investment income/(loss) | -20.0 | -6.0 | -148.6 | 1.4 |
Revenue stream YoY (%)
| Revenue stream YoY (%) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Share of box office income | — | -95.1 | 351.2 |
Sub-licensing | 1,867.7 | -81.4 | 205.1 |
Other media revenue | 196.0 | -83.7 | -52.6 |
Total | 9,678.4 | -97.4 | 900.8 |
Revenue stream (HKD Mn) (Half-Yearly)
| Revenue stream (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Share of box office income | 144.5 | 1.6 |
Sub-licensing | 30.9 | 0.2 |
Other media revenue | 1.2 | 3.8 |
Film investment income | 3.3 | 0.1 |
Total | 179.9 | 5.7 |
Income Statement and Per-Share Data
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Revenue + film investment income, net | 158.4 | 13.6 | 1,332.8 | 34.2 | 342.1 |
Cost of revenue | — | -106.3 | -426.5 | -219.3 | -580.1 |
Gross profit/(loss) | — | -92.6 | 906.3 | -185.1 | -238.0 |
Selling & distribution costs | — | -5.6 | -319.4 | -83.7 | -156.6 |
Administrative expenses | — | -123.3 | -138.2 | -122.3 | -120.1 |
Gain/(loss) on film investment funds from investors | — | 0 | -268.2 | 112.1 | 56.9 |
Operating income | -222.4 | -221.2 | 212.9 | -273.9 | -507.9 |
EBITDA (operating income + depreciation & intangible amortisation; film amortisation treated as content cost) | — | -205.1 | 226.5 | -260.3 | -497.3 |
EBITDA (aggregator, TipRanks/etnet basis incl. film amortisation add-back) | 20.3 | -117.3 | 519.8 | -38.7 | -101.7 |
Pre-tax income | -220.0 | -223.3 | 212.1 | -272.0 | -508.2 |
Income tax (expense)/credit | — | 1.5 | -53.0 | 11.2 | 9.8 |
Net income attributable to owners | -235.6 | -221.8 | 159.1 | -260.8 | -498.3 |
EPS basic (HKD) | -0.07 | -0.06 | 0.04 | -0.07 | -0.14 |
EPS diluted (HKD) | -0.07 | -0.06 | 0.04 | -0.07 | -0.14 |
Dividend per share (HKD) | 0 | 0 | 0 | 0 | 0 |
Margin (%)
| Margin (%) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Gross margin | -38.6 | -679.5 | 68.0 | -541.7 | -69.6 |
Operating margin | -140.5 | -1,623.0 | 16.0 | -801.5 | -148.5 |
EBITDA margin (dossier definition) | — | -1,504.8 | 17.0 | -761.6 | -145.4 |
Net margin | -148.8 | -1,627.4 | 11.9 | -763.1 | -145.7 |
Income Statement and Key Financials (HKD)
| Metric (HKD Mn) | H1 2025 | H1 2026 |
|---|---|---|
Revenue + film investment income | 179.9 | 5.7 |
Gross loss | -17.6 | -3.9 |
Selling & distribution | -54.3 | -0.2 |
Administrative expenses | -52.8 | -35.1 |
Operating loss | -100.7 | -40.2 |
Net loss | -102.2 | -40.1 |
LPS (HKD) | -0.03 | -0.01 |
Expense (HKD Mn)
| Expense (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|
Amortisation of film/TV rights | 84.0 | 289.1 | 219.1 | 395.6 |
Impairment of film/TV rights | 6.1 | 106.2 | 0.2 | 184.5 |
Impairment of financial & contract assets | 8.5 | 3.4 | 21.9 | 63.7 |
Advertising & marketing | 5.6 | 319.4 | 83.7 | 156.6 |
Employee benefits (ex-directors) | 56.3 | 48.4 | 46.2 | 54.9 |
Directors' remuneration | 21.3 | 38.6 | 23.3 | 21.1 |
Balance Sheet and Per-Share Data
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Total assets | 2,261.7 | 2,210.3 | 2,234.2 | 1,948.2 | 1,387.7 |
Cash & cash equivalents | 115.4 | 53.6 | 310.1 | 145.0 | 88.1 |
Film & TV programme rights (net) | — | 937.8 | 1,334.0 | 1,275.7 | 841.1 |
Prepayments for film & TV rights | — | 813.7 | 387.2 | 359.6 | 335.7 |
Bank/other borrowings — short-term | — | 108.3 | 0 | 0 | 0 |
Bank/other borrowings — long-term | — | 0 | 0 | 42.4 | 0 |
Lease liabilities (total) | — | 29.9 | 17.9 | 14.3 | 8.7 |
Net debt (borrowings + leases − cash) | — | 84.6 | -292.3 | -88.2 | -79.4 |
Film investment funds from investors (quasi-debt) | — | 524.5 | 535.2 | 519.0 | 437.0 |
Total liabilities | 606.4 | 881.9 | 780.7 | 793.7 | 691.1 |
Total equity | 1,655.3 | 1,328.4 | 1,453.6 | 1,154.4 | 696.6 |
Goodwill | 0 | 0 | 0 | 0 | 0 |
Intangible assets (ex-film rights) | — | 0 | 0 | 0 | 0 |
Net current assets (working capital) | 760 | 654.4 | 735.5 | 474.0 | 33.3 |
NAV per share (HKD) | 0.45 | 0.36 | 0.40 | 0.32 | 0.19 |
Cash Flow
| Metric (HKD Mn) | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Operating cash flow | -469.5 | -46.4 | 364.3 | -189.7 | -45.5 |
Net investing cash flow | -0.3 | 4.1 | 23.1 | 1.4 | 0.1 |
Free cash flow (proxy: OCF + net investing) | -469.8 | -42.3 | 387.4 | -188.3 | -45.4 |
Net financing cash flow | 440.6 | -13.3 | -128.3 | 28.6 | -16.1 |
Dividends paid | 0 | 0 | 0 | 0 | 0 |
Share buybacks (HKD Mn) | — | 0 | 0 | 0 | 0 |
Net change in cash | -29.3 | -55.6 | 259.1 | -159.7 | -61.5 |
Returns & Leverage Ratios (%) and Financial Ratios (x)
| Ratio | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
ROE (%, net income / average equity) | -15.2 | -14.9 | 11.4 | -20.0 | -53.8 |
ROA (%, net income / average assets) | -11.8 | -9.9 | 7.2 | -12.5 | -29.9 |
ROCE (%, etnet; proxy for ROIC) | -14.0 | -16.3 | 10.9 | -21.4 | -68.1 |
Current ratio (x) | 2.31 | 1.77 | 1.95 | 1.65 | 1.05 |
Total debt / equity (%, etnet incl. leases) | 7.4 | 10.4 | 1.2 | 4.9 | 1.2 |
Gearing (borrowings / (equity + borrowings), company definition) | — | 0.08 | 0 | 0.04 | 0 |
Net debt / EBITDA (x, dossier EBITDA; negative = net cash or negative EBITDA) | — | -0.41 | -1.29 | 0.34 | 0.16 |
Interest coverage (x, operating income / finance costs; negative = not meaningful) | — | -37.5 | 43.2 | -487.4 | -301.8 |
Asset turnover (x, revenue / average assets) | 0.08 | 0.01 | 0.60 | 0.02 | 0.21 |
Total liabilities / total assets (%) | 26.8 | 39.9 | 34.9 | 40.7 | 49.8 |
Revenue by Region
| Region (HKD Mn) | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
Total group revenue + investment income | 1,332.8 | 34.2 | 342.1 |
Revenue by Region and Region Assets & Liabilities
| Metric (HKD Mn) | FY2024 | FY2025 |
|---|---|---|
VIE group revenue + film investment income (incl. intra-group) | 14.7 | 66.4 |
VIE group assets | 435.7 | 353.7 |
Share Price History
| Date | Price | Context | Source |
|---|---|---|---|
24 Jan 2020 | +43% intraday | Lost in Russia online premiere | uSmart |
Early 2024 | About 0.57–0.71 | — | Moomoo news snippets |
11 Nov 2025 | 0.385 close | C River signing date | FY2025 results |
19 May 2026 | 0.275 close (5-day average 0.249) | Phancy signing date | Interim 2026 |
20 May 2026 | 0.315 (open +14.55%) | AI partnership reaction | Zhitong Finance |
Mid-2026 (latest observed) | 0.196–0.214 | etnet quotes (03 Jul 2026 and undated snapshots) | etnet |
Valuation Snapshot
| Multiple | Value | Basis |
|---|---|---|
Market cap | ≈HK$877m | 4,384.1m shares × 0.20 |
Enterprise value (ex-investor funds) | ≈HK$625m | Market cap − cash 260.9 + leases 9.5 (H1 2026) |
EV including film investment funds | ≈HK$1,056m |
|
EV/Sales (FY2025) | ≈1.8x | 625 / 342.1 |
EV/Sales (TTM) | ≈3.7x | TTM revenue ≈HK$167.8m |
P/B | ≈0.95x | NAV/share HK$0.21 (H1 2026) |
Share Count (m) and Per-Share Data
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
Shares in issue, year-end (m) | 3,656.5 | 3,656.5 | 3,656.5 | 3,656.5 | 3,656.5 |
Weighted average shares (m) | 3,600 | 3,656.5 | 3,656.5 | 3,656.5 | 3,656.5 |
EPS (HKD) | -0.07 | -0.06 | 0.04 | -0.07 | -0.14 |
NAV per share (HKD) | 0.45 | 0.36 | 0.40 | 0.32 | 0.19 |
DPS (HKD) | 0 | 0 | 0 | 0 | 0 |
Analyst Conclusions
Management guidance
-
No numeric guidance.
-
Release dates for Li Na, Intercross and Deep in the Mountains depend on approvals, market conditions and distribution.
-
AI tools will be introduced in phases, with the financial impact delayed.
-
Cost control continues.
-
The Full River Red II discussions with Zhang Yimou continue.
Consensus
Not available (no coverage).
Bull case
-
One hit resets the equity story. FY2023 showed a single Zhang Yimou tentpole can deliver HK$1.29bn of box office share. At a market cap of about HK$0.9bn, a credible Li Na or Full River Red II success is a step-change.
-
The balance sheet has been de-risked. Cash is HK$261m, there is no bank debt, and the FY2025 impairments (HK$184.5m) have already reset carrying values. P/B is about 0.95x.
-
Costs are now structurally lower. H1 2026 administrative expenses ran at about HK$70m annualised versus HK$120m in FY2025, which lowers the break-even revenue required.
Bear case
-
Hit dependence without hits. Four loss years in five, a 2025 slate that missed expectations, and zero releases in H1 2026. Library impairment risk persists on HK$906m of film rights.
-
Liquidity overhang. HK$230.3m owed to one investor is past its original due date. The Phancy HK$201m equity has fallen away. The FY2025 going-concern uncertainty may recur in the FY2026 audit.
-
The AI narrative is unproven and losing partners. None of the HK$100m AI budget had been deployed by H1 2026. The Phancy partnership's equity leg failed, and the US$20m API commitment's funding source is unclear.
Catalysts and monitorables (next 12 months)
-
Li Na release licence and release date.
-
Resolution of the HK$230.3m investor-fund liability (conversion into other films, settlement or extension).
-
Post-termination status of the Phancy JV and API agreements, and whether a replacement investor emerges.
-
Deployment of the AI budget by December 2026, as committed.
-
Full River Red II production start.
-
FY2026 audit opinion (going concern), expected around March 2027.
-
Chairman appointment.
-
Share price relative to the HK$0.44 warrant exercise price and the HK$0.30 C River entry price.
-
Changes in Maoyan's and Bilibili's holdings; activity by C River, which could become a 28.5% holder.
Analyst verdict
Huanxi Media is, at its core, a venture-style option on a handful of premium Chinese films, wrapped in a listed shell with a thin operating base. Its founding thesis is still visible in the 2025 Annual Report's director appendix: equity alignment with China's most bankable directors produces proprietary access to hits. That thesis was validated spectacularly once, with Full River Red in 2023. It has failed to repeat. The FY2025 slate turned HK$342m of revenue into a HK$498m loss, revealing how much P&A, amortisation and investor revenue-sharing absorb even in release years, and how quickly library values must be written down when a film disappoints.
The 2025–2026 response has been coherent but not yet convincing. The company shrank the team, stopped releasing into a weak market, raised HK$225m from C River at HK$0.30 and recast itself as an "AI + film" platform. But the AI pillar has no deployed capital, no disclosed output, and has just lost its second strategic partner's equity commitment. Meanwhile, a HK$230m investor liability sits past due. Governance has also weakened: there is no chairman, a founder breached dealing rules, and the founders' private studios compete for the same talent pipeline.
At roughly book value, the market is pricing the existing library and cash at par and assigning little value to the pipeline. This is not irrational. Li Na has been waiting for approval for years, and Full River Red II is only at concept stage. The verdict is speculative and catalyst-dependent: an avoid for fundamental, income or quality mandates, and a watchlist name for event-driven investors. The re-rating triggers are binary and observable: a Li Na release with credible box office, settlement of the investor-fund liability, and evidence of AI spending translating into lower production costs. Absent these, further dilution, impairment and going-concern scrutiny are the base case.
Unlock Company Financials
Unlock this company profile to view its financial data.
View Subscription PlansExecutive Leadership
Board of Directors
| Name | Role | Appointed | Age (AR2025) | Background / education | Shareholding (31 Dec 2025) |
|---|---|---|---|---|---|
Xiang Shaokun, Steven (項紹琨) | Executive Director & CEO | ED 2 Sep 2015; CEO 18 Sep 2015 | 63 | Former partner at Weil, Gotshal & Manges (led China practice from 2004) and Clifford Chance Shanghai (2002–04); M&A specialist (counsel to Lenovo on the IBM PC acquisition); JD Vanderbilt; BA Beijing University of International Relations; admitted in New York and Hong Kong | Not listed in directors' interests |
Hu Hui (呼惠) | Executive Director | 27 Jul 2025 | 48 | GM of Beijing Huanxi Shou Ying since 2014; producer of The Stage, She's Got No Name and Full River Red; formerly at Poly Huayi, Beida Huayi, Zhonglian Jinghua and ChinaVision Media (now Damai Entertainment, 1060.HK); BA English, Beijing Foreign Studies University | 8,480,000 shares (0.23%) |
Jiang Meng (姜萌) | Executive Director | 18 Jun 2026 | — | — | — |
Ning Hao (寧浩) | Non-Executive Director | 2 Sep 2015 | 48 | Film director/screenwriter (Crazy Stone, Breakup Buddies, Crazy Alien); Beijing Film Academy (photography, 2003) | 438,625,528 via Pacific Wits (12.00% pre-dilution); deemed 34.99% as concert party |
Xu Zheng (徐崢) | Non-Executive Director | 2 Sep 2015 | 53 | Actor/director (Lost in Thailand, Lost in Russia); Golden Horse Best Actor for Dying to Survive; Shanghai Theatre Academy (1994) | 438,625,528 via Tairong (12.00% pre-dilution); deemed 34.99% |
Wong Tak Chuen (黃德銓) | INED; Audit Committee Chair | 10 Apr 2014 | 61 | FCPA (HKICPA), FCA (ICAEW); practising CPA; formerly INED of Eternity Investment, China Healthwise and Man Sang | — |
Li Xiaolong (李小龍) | INED | 2 Sep 2015 | 60 | Founder and chairman of Net 263 Ltd. (002467.SZ); former independent director of Dangdang and KongZhong; Beijing University of Technology | 15,060,000 (0.41%) via Panfaith |
Wang Hong (王虹) | INED; Remuneration & Nomination Committee Chair | 2 Sep 2019 | 61 | VP of Hengdian Group; former chairman of Hengdian Film & TV Production (Monkey King: Hero is Back); former CEO of Asian Union New Media; UIBE economics (1988) | 200,000 (jointly with spouse) |
Song Pengliang (宋鵬亮) | INED | 18 Jun 2026 | — | — | — |
“—” = not publicly disclosed.
Board & Management Changes
| Date | Change | Context |
|---|---|---|
27 Jul 2025 | Dong Ping resigns as Chairman, ED and member of the RemCo and NomCo; Hu Hui appointed ED and to the RemCo and NomCo | Chairman seat left vacant; deviation from CG Code C.2.1 for 2025 |
15 Sep 2025 | Li Ni resigns as NED | Reason not given in sources reviewed |
18 Jun 2026 | Jiang Meng appointed ED; Song Pengliang appointed INED | Board expanded to 9 (3 ED / 2 NED / 4 INED) |
10 Aug 2026 | Remuneration Committee reconstituted (one appointment and one resignation effective 10 Aug 2026) | Names not captured in sources reviewed |
Directors' Remuneration
| Metric (HKD Mn) | FY2022 | FY2023 | FY2024 | FY2025 | H1 2026 |
|---|---|---|---|---|---|
Total directors' remuneration | 21.3 | 38.6 | 23.3 | 21.1 | 6.6 |
Shareholding Trend
| Holder | Shares | % at 31 Dec 2025 | Pro-forma % post-Apr 2026 (assumes no other changes) | Source |
|---|---|---|---|---|
C River Limited (affiliate of C River Co, Cayman) | 727,638,000 | 0 | 16.60 | Interim 2026 |
Pacific Wits Ltd (Ning Hao) | 438,625,528 | 12.00 | 10.00 | AR2025 |
Tairong Holdings Ltd (Xu Zheng) | 438,625,528 | 12.00 | 10.00 | AR2025 |
Dong Ping (direct + Newwood 265.2m + Numerous Joy 92.3m + Highrise 0.8m) | 402,063,298 | 11.00 | 9.17 | AR2025 |
Bilibili Inc. | 328,366,954 | 8.98 | 7.49 | AR2025 (notified 31 Dec 2024) |
Maoyan Entertainment | 208,430,000 | 5.70 | 4.75 | AR2025 (disclosed 14 Oct 2022) |
Li Xiaolong (Panfaith) | 15,060,000 | 0.41 | 0.34 | AR2025 |
Hu Hui | 8,480,000 | 0.23 | 0.19 | AR2025 |
Concert party under the 2015 shareholders' agreement (Dong, Ning, Xu and vehicles) | 1,279,314,354 | 34.99 | 29.18 | AR2025 |
Competitive Landscape
Key Competitors
| Competitor | Listing | Overlap with Huanxi | Relative positioning |
|---|---|---|---|
Maoyan Entertainment | 1896.HK | Film investment and distribution; also Huanxi's key distributor and a shareholder | Far larger and more diversified (ticketing, distribution); partner-competitor |
Damai Entertainment (formerly Alibaba Pictures) | 1060.HK | Film investment and production, distribution, IP | Backed by Alibaba; much larger platform and data assets |
Lemon Film & TV (Ningmeng) | 9857.HK | Film and series production | Larger series business |
Straw Bear Entertainment | 2125.HK | Series and film production | Series-weighted |
Bona Film Group | 001330.SZ | Film production/investment, cinemas | Vertically integrated (cinemas) |
Wanda Film | 002739.SZ | Production, distribution, cinemas | China's largest cinema chain |
China Film Co. | 600977.SH | State-owned production, distribution, exhibition | Policy-favoured; dominant distributor |
Huayi Brothers | 300027.SZ | Film production | Director-alliance model similar to Huanxi's; also financially stressed |
Enlight Media | 300251.SZ | Film production (animation; the Ne Zha franchise) | Animation leader |
iQIYI / Tencent Video / Youku / Mango TV | IQ (NASDAQ); 700.HK; BABA; 300413.SZ | SVOD, competing with huanxi.com | Orders of magnitude larger; huanxi.com is niche |
Founder-affiliated studios (Ning Hao's 壞猴子 entities; Xu Zheng's 真樂道 entities) | Private | Directors' own production companies (disclosed as competing interests) | Potential conflict: talent can route projects outside Huanxi |
Competitor Detail
| Metric | Huanxi (FY2025) |
|---|---|
Revenue | HK$342m |
Revenue growth YoY | +900.8% |
Gross margin | -69.6% |
Net margin | -145.7% |
Recent Developments
--



